Checkpoint-blocker induced autoimmunity is associated with pretreatment T cell expression profiles and favourable outcome in melanoma
W. Ye, A Olsson-Brown, R. A. Watson, V. T. F. Cheung, R. D. Morgan, I. Nassiri, R. Cooper, C.A. Taylor, View ORCID ProfileO. Brain, R. N. Matin, N. Coupe, M. R. Middleton, M. Coles, J.J. Sacco, M. J. Payne, View ORCID ProfileB. P. Fairfax
doi: https://doi.org/10.1101/2020.06.23.20138594
W. Ye
1Oxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK
A Olsson-Brown
2The Clatterbridge Cancer Centre, Wirral, UK
3University of Liverpool, Liverpool, UK
R. A. Watson
4Department of Oncology, Churchill Hospital, Oxford, UK
8The MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
V. T. F. Cheung
5Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK
9NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
R. D. Morgan
6Department of Oncology, The Christie NHS Foundation Trust, Manchester, UK
I. Nassiri
4Department of Oncology, Churchill Hospital, Oxford, UK
8The MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
R. Cooper
4Department of Oncology, Churchill Hospital, Oxford, UK
8The MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
C.A. Taylor
4Department of Oncology, Churchill Hospital, Oxford, UK
8The MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
O. Brain
5Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK
R. N. Matin
4Department of Oncology, Churchill Hospital, Oxford, UK
7Department of Dermatology, Churchill Hospital, Oxford, UK
N. Coupe
4Department of Oncology, Churchill Hospital, Oxford, UK
M. R. Middleton
8The MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
9NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
M. Coles
9NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
10Kennedy Institute of Rheumatology, NDORMS, University of Oxford, Oxford, UK
J.J. Sacco
2The Clatterbridge Cancer Centre, Wirral, UK
3University of Liverpool, Liverpool, UK
M. J. Payne
4Department of Oncology, Churchill Hospital, Oxford, UK
B. P. Fairfax
4Department of Oncology, Churchill Hospital, Oxford, UK
8The MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
9NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
Data Availability
All sequencing data will be made freely available to organizations and researchers to conduct research in accordance with the UK Policy Framework for Health and Social Care Research via a data access agreement. Sequence data will be deposited at the European Genome Phenome Archive, which is hosted by the European Bioinformatics Institute and the Centre for Genomic Regulation under accession no. EGAS00001004081. Patient anonymized irAE data will be shared on reasonable request.
https://ega-archive.org/search-results.php?query=EGAS00001004081
Posted June 24, 2020.
Checkpoint-blocker induced autoimmunity is associated with pretreatment T cell expression profiles and favourable outcome in melanoma
W. Ye, A Olsson-Brown, R. A. Watson, V. T. F. Cheung, R. D. Morgan, I. Nassiri, R. Cooper, C.A. Taylor, O. Brain, R. N. Matin, N. Coupe, M. R. Middleton, M. Coles, J.J. Sacco, M. J. Payne, B. P. Fairfax
medRxiv 2020.06.23.20138594; doi: https://doi.org/10.1101/2020.06.23.20138594
Checkpoint-blocker induced autoimmunity is associated with pretreatment T cell expression profiles and favourable outcome in melanoma
W. Ye, A Olsson-Brown, R. A. Watson, V. T. F. Cheung, R. D. Morgan, I. Nassiri, R. Cooper, C.A. Taylor, O. Brain, R. N. Matin, N. Coupe, M. R. Middleton, M. Coles, J.J. Sacco, M. J. Payne, B. P. Fairfax
medRxiv 2020.06.23.20138594; doi: https://doi.org/10.1101/2020.06.23.20138594
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (204)
- Emergency Medicine (372)
- Epidemiology (11629)
- Forensic Medicine (10)
- Gastroenterology (684)
- Genetic and Genomic Medicine (3636)
- Geriatric Medicine (342)
- Health Economics (623)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3392)
- Nursing (193)
- Nutrition (512)
- Oncology (1782)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6030)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)